Abstract Details

Title Assessment of Eslicarbazepine Acetate Monotherapy vs. Other Anti-Epileptic Drugs for Refractory Partial-Onset Seizures: Results of a Network Meta-Analysis Using Historical-Control Trials

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 023

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Fulton Velez PRESENTER	No disclosure on file
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
	No disclosure on file
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��